BCHE and early-onset autosomal dominant Alzheimer disease: Although debate is ongoing among physicians about the efficacy of cholinesterase inhibitors in treating Alzheimer’s disease [128], most research supports the benefits of promoting cholinergic activity in Alzheimer’s disease through the use of cholinesterase inhibitors.